Darren R Tate1, Ralph J Anderson. 1. Department of Obstetrics and Gynecology, John Peter Smith Hospital, Forth Worth, Tex 76104, USA.
Abstract
OBJECTIVE: The purpose of this study was to compare the recurrence rates of cervical dysplasia after ablation therapy and hysterectomy for women who are positive for the human immunodeficiency virus and for women who are negative for the human immunodeficiency virus. STUDY DESIGN: Forty-three women who were positive for the human immunodeficiency virus were compared with 103 patients who were negative for the human immunodeficiency virus after cryotherapy, laser ablation, loop electrosurgical excision procedure, conization, and hysterectomy for cervical dysplasia. All patients were followed up for at least 24 months. Patients with preexisting cervical cancer or with positive margins after treatment were excluded. RESULTS: Recurrence was higher in the HIV positive group for all modalities (73% vs 27%; P =.019). Higher recurrence rates were seen with CD4 counts <200 cells/mm3 (55% vs 26%). CONCLUSION: Hysterectomy fared better than standard therapy (50% vs 86%), but recurrences were significant.
OBJECTIVE: The purpose of this study was to compare the recurrence rates of cervical dysplasia after ablation therapy and hysterectomy for women who are positive for the human immunodeficiency virus and for women who are negative for the human immunodeficiency virus. STUDY DESIGN: Forty-three women who were positive for the human immunodeficiency virus were compared with 103 patients who were negative for the human immunodeficiency virus after cryotherapy, laser ablation, loop electrosurgical excision procedure, conization, and hysterectomy for cervical dysplasia. All patients were followed up for at least 24 months. Patients with preexisting cervical cancer or with positive margins after treatment were excluded. RESULTS: Recurrence was higher in the HIV positive group for all modalities (73% vs 27%; P =.019). Higher recurrence rates were seen with CD4 counts <200 cells/mm3 (55% vs 26%). CONCLUSION: Hysterectomy fared better than standard therapy (50% vs 86%), but recurrences were significant.
Authors: Groesbeck P Parham; Vikrant V Sahasrabuddhe; Mulindi H Mwanahamuntu; Bryan E Shepherd; Michael L Hicks; Elizabeth M Stringer; Sten H Vermund Journal: Gynecol Oncol Date: 2006-07-27 Impact factor: 5.482
Authors: Robert N Goldstone; Shirin R Hasan; Steven Drury; Teresa M Darragh; Annemieke van Zante; Stephen E Goldstone Journal: Int J Colorectal Dis Date: 2016-10-21 Impact factor: 2.571
Authors: Laura L Reimers; Susan Sotardi; David Daniel; Lydia G Chiu; Anne Van Arsdale; Daryl L Wieland; Jason M Leider; Xiaonan Xue; Howard D Strickler; David J Garry; Gary L Goldberg; Mark H Einstein Journal: Gynecol Oncol Date: 2010-10 Impact factor: 5.482
Authors: Jennifer R Moodley; Deborah Constant; Margaret Hoffman; Anna Salimo; Bruce Allan; Ed Rybicki; Inga Hitzeroth; Anna-Lise Williamson Journal: BMC Cancer Date: 2009-08-07 Impact factor: 4.430
Authors: Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Krista S Pfaendler; Victor Mudenda; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham Journal: AIDS Date: 2009-03-27 Impact factor: 4.177
Authors: Hugo De Vuyst; Nelly R Mugo; Silvia Franceschi; Kevin McKenzie; Vanessa Tenet; Julia Njoroge; Farzana S Rana; Samah R Sakr; Peter J F Snijders; Michael H Chung Journal: PLoS One Date: 2014-10-24 Impact factor: 3.240
Authors: Yasmin Adam; Cyril J van Gelderen; Guy de Bruyn; James A McIntyre; Diane A Turton; Neil A Martinson Journal: BMC Cancer Date: 2008-07-25 Impact factor: 4.430